Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma

BACKGROUND: Although immunotherapy works well in glioblastoma (GBM) preclinical mouse models, the therapy has not demonstrated efficacy in humans. To address this anomaly, we developed a novel humanized microbiome (HuM) model to study the response to immunotherapy in a preclinical mouse model of GBM...

Descripción completa

Detalles Bibliográficos
Autores principales: Dees, Kory J, Koo, Hyunmin, Humphreys, J Fraser, Hakim, Joseph A, Crossman, David K, Crowley, Michael R, Nabors, L Burton, Benveniste, Etty N, Morrow, Casey D, McFarland, Braden C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967908/
https://www.ncbi.nlm.nih.gov/pubmed/33758825
http://dx.doi.org/10.1093/noajnl/vdab023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967908/
https://www.ncbi.nlm.nih.gov/pubmed/33758825
http://dx.doi.org/10.1093/noajnl/vdab023

Ejemplares similares